Blue Square Asset Management, LLC Hepion Pharmaceuticals, Inc. Transaction History

Blue Square Asset Management, LLC

  • $185 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020
SELL
$2.84 - $4.59 $11 - $18
-4 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$1.31 - $3.09 $5 - $12
4 New
4 $0

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $45.7M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Blue Square Asset Management, LLC Portfolio

Follow Blue Square Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Square Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Square Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email